Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-24

Clinical Trial Update: Role of Vitamin K2 in Chronic Kidney Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the effects of Vitamin K2 in chronic kidney disease is currently recruiting at Tanta University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin K2 (menaquinone) (menaquinone)

Snippet

Sponsor: Tanta University | Conditions: Chronic Kidney Diseases | Phase 4 | Status: RECRUITING